C12Y 301/05
Triphosphoric monoester hydrolases
Official title: Triphosphoric monoester hydrolases (3.1.5)
C12Y301/05 (Triphosphoric monoester hydrolases) appears on 8 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 7
- Assignees
- 7
- Inventors
- 25
- Latest grant
- 29 Mar 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 2 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Methods for treating and preventing multiple sclerosis29 Mar 2016US 9,296,824 B2The Trustees of Columbia University in the City of New York
- Assays and reagents for identifying anti-fungal agents, and uses related thereto27 Apr 2004US 6,727,082 B1GPC Biotech AG
- Candida geranylgeranyl-protein transferase polypetide, compositions and methods related thereto24 Feb 2004US 6,696,280 B2GPC Biotech AG
- Antisense modulation of human Rho family gene expression25 Jun 2002US 6,410,323 B1Isis Pharmaceuticals, Inc.
- Mitofusin genes and their uses4 Sep 2001US 6,284,507 B1The Board of Trustees of the Leland Stanford Junior University
- Insect-derived short peptide for improving abscisic acid (ABA) content in cruciferous plant19 Jun 2025US 2025/0197461 A1Gannan Normal University
- Efficiency of viral delivery to cell lines differentiated from induced pluripotent stem cells31 Oct 2024US 2024/0360478 A1The Regents of the University of California
- Methods for Treating and Preventing Multiple Sclerosis18 Aug 2016US 2016/0237168 A1The Trustees of Columbia University in the City of New York
- A composition for preventing or treating an rna viral infection comprising samhd1 or a nucleic acid molecule encoding the samhd112 Nov 2015US 2015/0320842 A1Snu R&Db Foundation
- Methods for treating and preventing multiple sclerosis3 Jun 2010US 2010/0136002 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Antisense modulation of RhoA expression47US 5,945,290 AIsis Pharmaceuticals, Inc. · 1999
- Mitofusin genes and their uses19US 6,127,159 AThe Board of Trustees of the Leland Stanford Junior University · 2000
- Antisense modulation of human Rho family gene expression15US 6,410,323 B1Isis Pharmaceuticals, Inc. · 2002
- Mitofusin genes and their uses7US 6,284,507 B1The Board of Trustees of the Leland Stanford Junior University · 2001
- Candida geranylgeranyl-protein transferase polypetide, compositions and methods related thereto1US 6,696,280 B2GPC Biotech AG · 2004